These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3288951)

  • 1. Oxybutynin efficacy in the treatment of primary enuresis.
    Lovering JS; Tallett SE; McKendry JB
    Pediatrics; 1988 Jul; 82(1):104-6. PubMed ID: 3288951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients].
    Marconi AM; Felici E; Roggia A; Torelli F
    Pediatr Med Chir; 1985; 7(4):573-6. PubMed ID: 3915547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
    Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
    J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis.
    Varan B; Saatçi U; Ozen S; Bakkaloğlu A; Beşbaş N
    Turk J Pediatr; 1996; 38(2):155-9. PubMed ID: 8701478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL; Stokes A; Salzman PM
    J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
    Radvanska E; Kovács L; Rittig S
    J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An update on clinical and therapeutic aspects of nocturnal enuresis].
    Chiozza ML
    Pediatr Med Chir; 1997; 19(5):385-90. PubMed ID: 9493232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.
    Van Arendonk KJ; Austin JC; Boyt MA; Cooper CS
    Urology; 2006 May; 67(5):1049-53; discussion 1053-4. PubMed ID: 16698366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine to treat primary nocturnal enuresis: double-blind study.
    Al-Waili NS
    Eur J Med Res; 2000 Jan; 5(1):40-4. PubMed ID: 10657288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oxybutynin treatment on cognition in children with diurnal incontinence.
    Sommer BR; O'Hara R; Askari N; Kraemer HC; Kennedy WA
    J Urol; 2005 Jun; 173(6):2125-7. PubMed ID: 15879864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older pharmacologic therapy for nocturnal enuresis.
    Rushton HG
    Clin Pediatr (Phila); 1993 Jul; Spec No():10-3. PubMed ID: 8039332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels and efficacy of imipramine treatment for enuresis.
    Fritz GK; Rockney RM; Yeung AS
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):60-4. PubMed ID: 8138522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
    Kilic N; Balkan E; Akgoz S; Sen N; Dogruyol H
    Int J Urol; 2006 Feb; 13(2):105-8. PubMed ID: 16563131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.